Yes, there are multiple treatments for vitiligo, and options have expanded significantly in recent years. No single treatment works for everyone, and results depend on factors like where the patches are on your body, how much skin is affected, and whether the condition is still spreading. But most people who pursue treatment see at least partial return of their natural skin color, especially on the face and neck.
Topical Steroid Creams
Prescription steroid creams are one of the most common first-line treatments. They work by calming the immune response that’s attacking your skin’s pigment-producing cells. For patches on the arms, legs, or trunk, a high-potency steroid ointment is typically applied twice daily for two weeks, followed by one week off to give the skin a break. This on-off cycle repeats for three to six months to judge whether the treatment is working.
The cycling matters because continuous use of potent steroids thins the skin over time. Your dermatologist will likely choose a milder strength for more delicate areas like the face or groin, or switch to a different type of medication altogether for those spots.
Calcineurin Inhibitors for the Face and Neck
For facial vitiligo, a class of non-steroidal creams called calcineurin inhibitors (tacrolimus and pimecrolimus) has become a go-to option. These suppress the local immune attack without the skin-thinning risk of steroids, making them safer for long-term use on sensitive areas.
Facial patches respond far better to tacrolimus than patches elsewhere on the body. In one six-month study, 68% of patients with facial or neck lesions achieved greater than 75% repigmentation using tacrolimus twice daily. By comparison, only 13% of trunk lesions and 6% of upper extremity lesions hit that same benchmark. In children, nearly half with head and neck involvement saw strong repigmentation. Areas like palms, soles, fingertips, and lips respond minimally, so these creams are best suited above the shoulders.
Phototherapy
Narrowband UVB phototherapy is the most widely used light-based treatment and is often recommended when vitiligo covers larger areas or when creams alone aren’t enough. Sessions involve standing in a light booth that delivers a specific wavelength of ultraviolet light to stimulate dormant pigment cells in hair follicles to migrate back into the skin.
The standard schedule is two to three sessions per week. Many dermatologists recommend starting at three times weekly for the first three months, then stepping down to twice weekly. Repigmentation typically begins appearing as small dots of color (often around hair follicles) within a few months, though a full course can take a year or longer. Consistency matters: skipping sessions slows progress noticeably. The face, neck, and trunk tend to respond best, while hands and feet are slower to repigment.
Excimer Laser for Small Patches
If you have just a few small patches, an excimer laser delivers a concentrated beam of UVB light directly to the affected skin without exposing the surrounding area. This makes it a good fit for localized vitiligo, particularly on the face. In a case series of patients with facial vitiligo treated with the excimer laser alongside a topical vitamin D cream, all achieved greater than 75% repigmentation over 10 to 20 weeks. Two patients reached that level in about 20 sessions, while one required 40 sessions.
Excimer laser visits are typically scheduled two to three times per week, similar to booth phototherapy. The main advantage is precision: only the white patches get the UV dose, which reduces cumulative sun exposure to normal skin.
Ruxolitinib Cream (Opzelura)
Approved by the FDA in 2022, ruxolitinib cream is the first medication specifically approved for repigmentation in vitiligo. It belongs to a class of drugs called JAK inhibitors, which block the specific immune signaling pathway that drives pigment cell destruction.
In two large clinical trials, about 30% of patients using ruxolitinib cream achieved 75% or greater improvement in facial vitiligo scores at 24 weeks, compared to roughly 8 to 11% of patients using a placebo cream. Those numbers continue to improve with longer use. The cream is applied twice daily, and it’s most effective on the face and neck, with slower results on the body and extremities. Side effects are generally mild, with application-site acne being the most commonly reported issue.
Surgical Transplant Options
For vitiligo that has been completely stable (no new patches and no expansion of existing ones) for at least 12 months, surgical options become viable. The most established technique involves taking a thin sample of your own normally pigmented skin, separating out the pigment-producing cells and surrounding skin cells, and transplanting them onto the depigmented areas.
Stability is the key requirement. If vitiligo is still active, transplanted cells are likely to be attacked by the same immune process that caused the original patches. Some earlier studies used a six-month stability window, but most experts now consider 12 months the minimum for a favorable surgical outcome. The best candidates have segmental vitiligo (affecting one side of the body) or stable, well-defined patches that haven’t responded to other treatments.
Depigmentation for Extensive Vitiligo
When vitiligo covers more than 50% of the body’s surface, some people choose the opposite approach: removing the remaining pigment to create a uniform, lighter skin tone. A topical cream containing monobenzone is applied to the normally pigmented skin over many months, gradually and permanently lightening it. This is an irreversible decision, and the resulting skin will be highly sensitive to sun, requiring lifelong sun protection. It’s typically considered only when repigmentation treatments haven’t worked and the remaining scattered patches of normal color create more distress than a uniform appearance would.
Combining Treatments for Better Results
In practice, most dermatologists combine approaches rather than relying on a single one. A common strategy pairs phototherapy with a topical treatment like tacrolimus or ruxolitinib cream, which can speed repigmentation compared to either treatment alone. Adding a topical vitamin D analogue alongside phototherapy or excimer laser is another well-established combination.
One small clinical trial also explored an oral supplement angle: participants taking 60 mg of ginkgo biloba extract twice daily for 12 weeks showed measurable improvement in vitiligo scores and reduced spread. While this isn’t a standalone treatment, some dermatologists suggest it as a low-risk add-on, particularly for patients whose vitiligo is actively spreading.
What Affects Your Results
Location is the single biggest predictor of treatment success. The face and neck repigment most reliably because those areas have a dense supply of pigment cells in hair follicles, which serve as the source for new pigment. The trunk and proximal limbs (upper arms, thighs) respond moderately well. Hands, feet, wrists, and lips are the most resistant areas, often requiring longer treatment courses and combination strategies.
Darker skin tones often show more dramatic repigmentation because there’s a greater reservoir of pigment cells. Patches that still contain dark hairs tend to respond better than those where the hair has also turned white, since white-haired patches have lost the follicular pigment cells that drive recovery. Age of the patches matters too: newer vitiligo generally responds faster than patches present for many years.
Most treatments require months of consistent use before results become visible. A three-to-six-month trial is standard before deciding whether a given approach is working. Stopping too early is one of the most common reasons people feel treatment “didn’t work.”